Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06320639
Other study ID # UGustaveEiffel
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 3, 2023
Est. completion date October 10, 2026

Study information

Verified date March 2024
Source University Gustave Eiffel
Contact Maud Ranchet, PhD
Phone 0472142599
Email maud.ranchet@univ-eiffel.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The ageing of the population is leading to an increasing number of older drivers on the roads. At the same time, the proportion of older people with pathological ageing and neurocognitive disorders (NCD) is increasing. In terms of road safety, this raises the question of whether these drivers should continue to drive or not. People with NCDs may not be aware of the presence, extent and progression of their cognitive impairment and the impact it can have on daily life, including driving. Despite their loss of autonomy and medical advice, 22% of people with major NCD continue to drive. In addition, the presence of minor NCD also puts people at a higher risk of road accidents. However, several studies demonstrated that an NCD does not lead to a systematic and immediate impairment of driving ability and abruptly stopping driving leads to health problems, such as the risk of depression and greatly reduces quality of life. It is therefore relevant to focus research on driving with people with NCD in order to have a reliable indicator of the person's abilities and the impact of their cognitive impairment on driving activity. The proposed study seeks to meet this need by studying the performance of people with NCD on a driving station (mini-simulator) while assessing their ability to evaluate their performance. To achieve this goal, people with NCDs will perform tasks on a driving simulator. In addition, after each task on the driving simulator, they will answer questions about how they evaluate their own driving. Two assessors will observe the participants' driving and will estimate their driving performance. By comparing the driver's self-assessment with the assessors' assessment, an "awareness score of driving ability" will be calculated to determine whether the driver correctly assessed his or her performance. Another project already underway aims to collect similar data from people without a diagnosis of NCDs (control group). The principal objective of the present study is to compare the driving performance in a simulator and the awareness of driving ability of people with NCDs with those of a control group. Secondary objectives are : 1. to measure driving performance in a simulator and awareness of driving abilities (i.e. self-assessment skills) of people with NCDs. 2. to analyse driving performance and awareness of driving abilities according to the diagnosis and severity of the disorder (i.e. minor or major neurocognitive disorders). 3. to establish a methodology to identify a driver at risk of dangerous driving. It is mainly an exploratory study however some hypotheses can be made : - The driving performance and awareness of driving skills of people with NCDs are poorer compared to those of older, control individuals. - Individuals' driving performance and awareness of driving ability are lower in the presence of major NCDs compared to minor NCDs.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date October 10, 2026
Est. primary completion date October 10, 2026
Accepts healthy volunteers No
Gender All
Age group 50 Years to 95 Years
Eligibility Inclusion Criteria: - Diagnosed with Neurocognitive Disorders according to the Diagnostic and Statistical Manual of Mental Disorders-V (DSM-V) - Normal or corrected vision - B licence holder with 3+ years driving experience - Active drivers or drivers who stopped driving less than 2 months ago (time between the medical consultation and the day in the day care hospital) - For participants able to give consent: - Written informed consent to participate in the study - Informed consent of the participant in the presence of his/her curator. - For participants who are not able to receive information and to give consent: - Written informed consent of the legal representative (tutor) for participants under tutelage. - Signature of a relative (family member and/or trusted person) of the participant - The participant has to be affiliated to a social security scheme. Exclusion Criteria: - History of epilepsy - People with vestibular disorders, motion sickness or migraines - Psychiatric history (e.g. schizophrenia) - Non-stabilized use of antidepressants and/or anxiolytics (started or modified within the last 3 months) - History of alcoholism - Use of anti-epileptics - Osteo-articular pathologies compromising walking

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Hôpital des Charpennes Villeurbanne

Sponsors (2)

Lead Sponsor Collaborator
University Gustave Eiffel Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

References & Publications (1)

Delphin-Combe F, Coste MH, Bachelet R, Llorens M, Gentil C, Giroux M, Paire-Ficout L, Ranchet M, Krolak-Salmon P. An innovative therapeutic educational program to support older drivers with cognitive disorders: Description of a randomized controlled trial — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Awareness score of driving ability After each task on the driving simulator, participants answer questions about what they think of their driving performance. Two experimenters write their observations about the participant's performance. Answers are coded in a way that a greater driving performance lead to a greater score.
The Awareness score is computed by subtracting the score given by the participant to the average of the scores given by the experimenters. The further away from zero the score is, the less aware the participants will be of their abilities. Zero will indicate a perfect assessment of one's abilities.
Up to 2 hours, from the inclusion until the end of the experiment (2 hours later)
Primary Driving performance variables measured by the driving simulator For each driving task, the driving variables of interest from the driving simulator will be collected: total braking response time, average speed and lateral lane position for the keeping lane task; distance between vehicles for the car-tracking task; reaction time to unexpected events for the rural and urban driving tasks. Up to 2 hours, from the inclusion until the end of the experiment (2 hours later)
See also
  Status Clinical Trial Phase
Recruiting NCT05754567 - CONCEPTT Kids International Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes
Completed NCT05080777 - Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems N/A
Not yet recruiting NCT03276377 - VItamin K Inhibition and NeurocoGnition (VIKING) N/A
Recruiting NCT04175223 - Impact of Probiotics in HIV-positive Patients With Neurocognitive Disorders N/A
Completed NCT03538522 - A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831 Phase 2
Recruiting NCT05732285 - A Pilot Randomized Controlled Trial: CoINTEGRATE N/A
Recruiting NCT04095962 - Effects of a Multicomponent Exercise Intervention on Physical and Cognitive Function of Older Adults With Dementia N/A
Not yet recruiting NCT04113577 - COgilus Remediation in Alzheimer Patients (CORA)
Recruiting NCT06105320 - COGNIFOOD-Changing the Carbohydrate/Fat-ratio to Prevent Cognitive Decline and Alzheimer Pathology: A Pilot Study N/A
Completed NCT03050385 - Cognitive Rehabilitation During Transcranial Direct Current Stimulation N/A
Active, not recruiting NCT06372002 - Effectiveness and Cost-Effectiveness of Cognitive Stimulation Therapy - Spain (CST-ES) in People Living With Dementia N/A
Recruiting NCT05508789 - A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5) Phase 3
Recruiting NCT03926351 - High Dose Omega 3 in People at Risk for Dementia Phase 2
Recruiting NCT05504681 - Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic
Completed NCT04168268 - Patient-reported Outcome Measures After Post-anesthesia Care Unit Delirium
Recruiting NCT04825847 - Neurocognitive Disorders After Major Surgery in Elderly N/A
Active, not recruiting NCT02958670 - Imaging Tau Deposition in the Brain of Elderly Subjects N/A
Enrolling by invitation NCT02652598 - Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD Phase 2
Completed NCT02825732 - MEMORA-Caregiver : Risk Factors of Caregiver Burden Among Patients With Neurocognitive Disorders or Subjective Cognitive Complaint N/A
Completed NCT04725708 - Cognitive Functions on Coronary Surgery N/A